{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:31:06Z","timestamp":1791268266935,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["U01HL099773"],"award-info":[{"award-number":["U01HL099773"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["P01 GM081629"],"award-info":[{"award-number":["P01 GM081629"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["P51 OD011106"],"award-info":[{"award-number":["P51 OD011106"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Charlotte Geyer Foundation"},{"name":"Department of Pharmacology"},{"name":"Faculty of Science"},{"name":"Mahidol University, Bangkok, Thailand"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.scr.2015.10.015","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T01:54:40Z","timestamp":1446256480000},"page":"678-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells"],"prefix":"10.1016","volume":"15","author":[{"given":"Kran","family":"Suknuntha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Y.J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Slukvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2015.10.015_bb0010","doi-asserted-by":"crossref","first-page":"e71596","DOI":"10.1371\/journal.pone.0071596","article-title":"Variable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation","volume":"8","author":"Bedel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.scr.2015.10.015_bb0015","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.scr.2015.10.015_bb0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-2141.2001.03192.x","article-title":"Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors","volume":"115","author":"Bhatia","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.scr.2015.10.015_bb0030","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2009-07-231845","article-title":"Generation of iPSCs from cultured human malignant cells","volume":"115","author":"Carette","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2141.2008.07368.x","article-title":"The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor","volume":"143","author":"Chin","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.scr.2015.10.015_bb0040","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1172\/JCI38591","article-title":"Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors","volume":"119","author":"Choi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.scr.2015.10.015_bb0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/stem.20080922","article-title":"Hematopoietic and endothelial differentiation of human induced pluripotent stem cells","volume":"27","author":"Choi","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.scr.2015.10.015_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.0811417","article-title":"Olfactomedin 4 defines a subset of human neutrophils","volume":"91","author":"Clemmensen","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.scr.2015.10.015_bb0055","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.scr.2015.10.015_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2014.06.001","article-title":"Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier","author":"Cosgun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2015.10.015_bb0075","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scr.2015.10.015_bb0080","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scr.2015.10.015_bb0085","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood-2013-01-478412","article-title":"Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia","volume":"121","author":"Gandre-Babbe","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0095","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrd3577","article-title":"Induced pluripotent stem cells--opportunities for disease modelling and drug discovery","volume":"10","author":"Grskovic","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.scr.2015.10.015_bb0100","doi-asserted-by":"crossref","first-page":"e85567","DOI":"10.1371\/journal.pone.0085567","article-title":"Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation","volume":"9","author":"Hasselbalch","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.scr.2015.10.015_bb0105","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1101\/gad.1213504","article-title":"Reprogramming of a melanoma genome by nuclear transplantation","volume":"18","author":"Hochedlinger","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.scr.2015.10.015_bb0110","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","article-title":"Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation","volume":"99","author":"Holtz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0115","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.V97.3.720","article-title":"Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3","volume":"97","author":"Holyoake","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0125","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1182\/blood-2010-07-298331","article-title":"Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells","volume":"117","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.6026\/97320630002428","article-title":"DAVID gene ID conversion tool","volume":"2","author":"Huang da","year":"2008","journal-title":"Bioinformation"},{"key":"10.1016\/j.scr.2015.10.015_bb0135","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1128\/MCB.24.19.8447-8456.2004","article-title":"GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I","volume":"24","author":"Huang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.scr.2015.10.015_bb0140","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1073\/pnas.96.22.12804","article-title":"Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia","volume":"96","author":"Jiang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.scr.2015.10.015_bb0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1349-7006.2006.00383.x","article-title":"Specific overexpression of OLFM4(GW112\/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis","volume":"98","author":"Koshida","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.scr.2015.10.015_bb0150","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1182\/blood-2011-07-367441","article-title":"Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples","volume":"119","author":"Kumano","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0155","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.scr.2015.10.015_bb0160","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/bioinformatics\/btt087","article-title":"EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments","volume":"29","author":"Leng","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.scr.2015.10.015_bb0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.scr.2015.10.015_bb0170","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1109\/TCBB.2009.25","article-title":"A cluster refinement algorithm for motif discovery","volume":"7","author":"Li","year":"2010","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinforma."},{"key":"10.1016\/j.scr.2015.10.015_bb0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scr.2015.10.015_bb0180","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.yexcr.2006.02.011","article-title":"The glycoprotein hGC-1 binds to cadherin and lectins","volume":"312","author":"Liu","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.scr.2015.10.015_bb0185","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1182\/blood-2009-10-246439","article-title":"Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis","volume":"116","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1423-0127-19-38","article-title":"Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells","volume":"19","author":"Liu","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.scr.2015.10.015_bb0195","article-title":"Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells","author":"Liu","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.scr.2015.10.015_bb0200","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.scr.2015.10.015_bb0205","article-title":"Non-irradiated NOD, B6.SCID Il2rg-\/- KitW41\/W41 (NBSGW) Mice Support Multi-lineage Engraftment of Human Hematopoietic Cells","author":"McIntosh","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.scr.2015.10.015_bb0210","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/1535-7163.MCT-12-0245","article-title":"Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage","volume":"11","author":"Miljkovic-Licina","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.scr.2015.10.015_bb0215","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-10-3152","article-title":"Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer","volume":"17","author":"Oh","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.scr.2015.10.015_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.scr.2015.10.015_bb0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10059-012-0251-7","article-title":"Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes","volume":"34","author":"Park","year":"2012","journal-title":"Mol. Cells"},{"key":"10.1016\/j.scr.2015.10.015_bb0230","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1242\/dev.128.22.4597","article-title":"Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid-myeloid potential","volume":"128","author":"Perlingeiro","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.scr.2015.10.015_bb0235","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V88.6.2162.bloodjournal8862162","article-title":"Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia","volume":"88","author":"Petzer","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0240","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.scr.2015.10.015_bb0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature12587","article-title":"Deterministic direct reprogramming of somatic cells to pluripotency","volume":"502","author":"Rais","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.scr.2015.10.015_bb0250","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/0008-5472.CAN-03-3656","article-title":"Effect of mutational inactivation of tyrosine kinase activity on BCR\/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors","volume":"64","author":"Ramaraj","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.scr.2015.10.015_bb0255","doi-asserted-by":"crossref","first-page":"e35824","DOI":"10.1371\/journal.pone.0035824","article-title":"Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors","volume":"7","author":"Ramos-Mejia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.scr.2015.10.015_bb0260","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","article-title":"BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells","volume":"115","author":"Schemionek","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.scr.2015.10.015_bb0270","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.scr.2015.10.015_bb0275","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1182\/blood-2009-10-247502","article-title":"Neoplastic blood cells become pluripotent","volume":"114","author":"Slukvin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0280","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1182\/blood-2013-07-474825","article-title":"Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells","volume":"122","author":"Slukvin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0285","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.scr.2015.10.015_bb0290","first-page":"S12 11","article-title":"AceView: a comprehensive cDNA-supported gene and transcripts annotation","volume":"7","author":"Thierry-Mieg","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.scr.2015.10.015_bb0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12035-009-8076-x","article-title":"Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology","volume":"40","author":"Tomarev","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.scr.2015.10.015_bb0300","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood.V80.10.2522.2522","article-title":"Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia","volume":"80","author":"Udomsakdi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0305","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood.V80.10.2513.2513","article-title":"Characterization of primitive hematopoietic cells in normal human peripheral blood","volume":"80","author":"Udomsakdi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","article-title":"OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells","volume":"137","author":"van der Flier","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.scr.2015.10.015_bb0315","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/leu.2011.250","article-title":"Frequency of leukemic initiating cells does not depend on the xenotransplantation model used","volume":"26","author":"Vargaftig","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.scr.2015.10.015_bb0320","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1172\/JCI115985","article-title":"Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV","volume":"90","author":"Verfaillie","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.scr.2015.10.015_bb0325","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2014-10-570234","article-title":"De novo generation of HSCs from somatic and pluripotent stem cell sources","volume":"125","author":"Vo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0330","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood-2004-04-1649","article-title":"Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential","volume":"105","author":"Vodyanik","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0335","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","article-title":"Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures","volume":"108","author":"Vodyanik","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0340","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2009-04-217406","article-title":"Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders","volume":"114","author":"Ye","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.scr.2015.10.015_bb0345","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.scr.2015.10.015_bb0350","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-1119(01)00763-6","article-title":"Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development","volume":"283","author":"Zhang","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.scr.2015.10.015_bb0355","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/0008-5472.CAN-03-3443","article-title":"GW112, a novel antiapoptotic protein that promotes tumor growth","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506115001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506115001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T22:26:56Z","timestamp":1653431216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506115001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1873506115001506"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2015.10.015","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2015.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}